Due to its ability to generate ROS, NADPH oxidase is considered to play a key role in atherosclerosis, and inhibitors of these enzyme have been shown to counteract plaque formation (Meyer and Schmitt, 2000; Yokoyama et al., 2000). Here, FMO5 is linked to atherosclerosis.